Cargando…

Prognostic evaluation of stage I lung adenocarcinoma based on systematic inflammatory response

BACKGROUND: This study aimed to construct an effective nomogram based on the clinical and laboratory characteristics to predict the prognosis of stage I lung adenocarcinoma with EGFR alteration. METHODS: A retrospective study was performed of 913 eligible patients with EGFR alteration after surgery...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Jia-Yi, Wu, Lei-Lei, Zhang, Li-Yan, Li, Kun, Li, Zhi-Xin, Zhao, Yong, Xie, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660118/ https://www.ncbi.nlm.nih.gov/pubmed/37941434 http://dx.doi.org/10.1093/jncics/pkad090

Ejemplares similares

A Novel Systematic Oxidative Stress Score Predicts the Survival of Patients with Early-Stage Lung Adenocarcinoma
por: Qian, Jia-Yi, et al.
Publicado: (2023)

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection
por: Shen, Yu-Jia, et al.
Publicado: (2021)

A systematic review and meta-analysis of the influence of STAS on the long-term prognosis of stage I lung adenocarcinoma
por: Yang, Yanhui, et al.
Publicado: (2021)

Systematic construction and validation of an immune prognostic model for lung adenocarcinoma
por: Luo, Chenghan, et al.
Publicado: (2019)

The Clinical and Prognostic Characteristics of Primary Salivary Gland-Type Carcinoma in the Lung: A Population-Based Study
por: Wu, Lei-Lei, et al.
Publicado: (2022)

Prognostic value of MMP9 activity level in resected stage I B lung adenocarcinoma
por: Yu, Yongfeng, et al.
Publicado: (2016)

The characterization of tumor microenvironment infiltration and the construction of predictive index based on cuproptosis-related gene in primary lung adenocarcinoma
por: Li, Kun, et al.
Publicado: (2022)

Development of a Prognostic Nomogram for Patients with Lung Adenocarcinoma in the Stages I, II, and III Based on Immune Scores
por: Xie, Hui, et al.
Publicado: (2021)

Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma
por: Luo, Wei-Ming, et al.
Publicado: (2018)

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients
por: Zhang, Yanwei, et al.
Publicado: (2020)

Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma
por: Deng, Jiajun, et al.
Publicado: (2020)

AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research
por: Wu, Lei-Lei, et al.
Publicado: (2023)

A clinical risk model for assessing the survival of patients with stage IA–IIA non-small cell lung cancer after surgery
por: Qian, Jia-Yi, et al.
Publicado: (2022)

Prognostic value of metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma
por: Wang, Xiao-Yi, et al.
Publicado: (2017)

Prognostic relevance of TTF-1 expression in stage I adenocarcinoma
por: Zhou, Chao, et al.
Publicado: (2017)

Prognostic Impact of the Findings on Thin-Section Computed Tomography in stage I lung adenocarcinoma with visceral pleural invasion
por: Yuan, Mei, et al.
Publicado: (2018)

The clinical-histologic and prognostic characteristics in patients with a second primary non-small-cell lung cancer after a lobectomy
por: Wu, Lei-Lei, et al.
Publicado: (2023)

Prognostic and predictive value of radiomic signature in stage I lung adenocarcinomas following complete lobectomy
por: Nie, Wei, et al.
Publicado: (2022)

Novel prognostic model for stratifying survival in stage I lung adenocarcinoma patients
por: Liu, Di-Han, et al.
Publicado: (2019)

LHX3 is an early stage and radiosensitivity prognostic biomarker in lung adenocarcinoma
por: Lin, Xin, et al.
Publicado: (2017)

Prognostic significance of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage I lung adenocarcinoma: A retrospective study based on analysis of 110 Chinese patients
por: Zhao, Xin, et al.
Publicado: (2017)

Prognostic significance of limited resection in pathologic stage I lung adenocarcinoma with spread through air spaces
por: Xu, Kuan, et al.
Publicado: (2023)

Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2017)

Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma
por: Enokida, Yasuaki, et al.
Publicado: (2016)

The prognostic significance of tumor spread through air space in stage I lung adenocarcinoma
por: Huang, Liling, et al.
Publicado: (2022)

Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
por: Xie, Dong, et al.
Publicado: (2020)

Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma
por: Xu, Jian-Zhao, et al.
Publicado: (2021)

Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma
por: Meaney, Claire L., et al.
Publicado: (2017)

Postoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I pulmonary adenocarcinoma
por: He, Ying, et al.
Publicado: (2017)

Outcomes of patients with different lepidic percentage and tumor size of stage I lung adenocarcinoma
por: Liu, Chia, et al.
Publicado: (2022)

Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma
por: Carretta, Angelo, et al.
Publicado: (2020)

Exonuclease 1 (EXO1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Lung Adenocarcinoma
por: Zhou, Chang-shuai, et al.
Publicado: (2021)

Percutaneous radiofrequency ablation for medically inoperable patients with clinical stage I non-small cell lung cancer
por: Liu, Baodong, et al.
Publicado: (2015)

Genetic and immunologic features of recurrent stage I lung adenocarcinoma
por: Kratz, Johannes R., et al.
Publicado: (2021)

A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers
por: Ren, Jin, et al.
Publicado: (2021)

Targeted Sequencing Analysis of Predominant Histological Subtypes in Resected Stage I Invasive Lung Adenocarcinoma
por: Li, Yan, et al.
Publicado: (2021)

A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
por: Liu, Chengming, et al.
Publicado: (2021)

Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters
por: Lv, Zhenyang, et al.
Publicado: (2020)

Distinct Prognostic Factors of Ground Glass Opacity and Pure-Solid Lesion in Pathological Stage I Invasive Lung Adenocarcinoma
por: Zhai, Wen Yu, et al.
Publicado: (2022)

HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma
por: Shao, Fengling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lbpf16fhduub582sr8m0vc4bcg